Research / NVT / Fundamental state Inspectable configuration
State dimensions Filing 0001720635-22-000018 General Corporate
Debt relative to revenue 31th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.debt_to_revenue
149.82% · OPTIONAL · VALID
Capex intensity 38th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.60% · OPTIONAL · VALID
Operating cash generation 6th Own-history percentile · N=16
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
0.94% · OPTIONAL · VALID
Share-count growth 75th Own-history percentile · N=12
Evidence method Yoy · gp.fundamentals.shares_outstanding
-0.79% · CORE · VALID
Revenue growth 92th Own-history percentile · N=12
Evidence method Yoy · gp.fundamentals.revenue
26.56% · CORE · VALID
Inventory pressure 94th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
50.14% · OPTIONAL · VALID
Gross margin 0th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.gross_margin
35.60% · CORE · VALID
Operating margin 38th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.operating_margin
12.97% · CORE · VALID
R&D intensity 75th Own-history percentile · N=16
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.19% · OPTIONAL · VALID
SBC intensity 94th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.95% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Sep 30, 2021 10/10 normalized Level 3 Dec 31, 2021 10/10 normalized Level 3 Mar 31, 2022 10/10 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 10/10 normalized Level 3 Mar 31, 2023 10/10 normalized Level 3 Jun 30, 2023 10/10 normalized Level 3 Sep 30, 2023 10/10 normalized Level 3 Dec 31, 2023 10/10 normalized Level 3 Mar 31, 2024 10/10 normalized Level 3 Jun 30, 2024 10/10 normalized Level 3 Sep 30, 2024 10/10 normalized Level 3 Dec 31, 2024 10/10 normalized Level 3 Mar 31, 2025 10/10 normalized Level 3 Jun 30, 2025 10/10 normalized Level 3 Sep 30, 2025 10/10 normalized Level 3 Dec 31, 2025 10/10 normalized Level 3 Mar 31, 2026 10/10 normalized Level 3 Jun 30, 2026 10/10 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 40.58%
Current 149.82%
Delta 109.24% Capex Intensity Decreased
Previous 1.60%
Current 1.60%
Delta -0.01% Cash Generation Decreased
Previous 15.16%
Current 0.94%
Delta -14.23% Dilution Increased
Previous -1.25%
Current -0.79%
Delta 0.46% Growth Increased
Previous 23.19%
Current 26.56%
Delta 3.38% Inventory Pressure Increased
Previous 13.07%
Current 50.14%
Delta 37.06% Margin Decreased
Previous 38.26%
Current 35.60%
Delta -2.66% Profitability Decreased
Previous 14.44%
Current 12.97%
Delta -1.47% R And D Intensity Increased
Previous 1.97%
Current 2.19%
Delta 0.21% Sbc Intensity Increased
Previous 0.67%
Current 0.95%
Delta 0.28% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.